Log in to save to my catalogue

Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with e...

Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with e...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_fe94db07000c43398bdc01449eceb2ce

Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with early-onset mild cognitive impairment

About this item

Full title

Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with early-onset mild cognitive impairment

Publisher

England: BioMed Central Ltd

Journal title

Journal of nanobiotechnology, 2023-02, Vol.21 (1), p.54-19, Article 54

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

In the clinical course of Alzheimer's disease (AD) development, the dementia phase is commonly preceded by a prodromal AD phase, which is mainly characterized by reaching the highest levels of Aβ and p-tau-mediated neuronal injury and a mild cognitive impairment (MCI) clinical status. Because of that, most AD cases are diagnosed when neuronal damag...

Alternative Titles

Full title

Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with early-onset mild cognitive impairment

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_fe94db07000c43398bdc01449eceb2ce

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_fe94db07000c43398bdc01449eceb2ce

Other Identifiers

ISSN

1477-3155

E-ISSN

1477-3155

DOI

10.1186/s12951-023-01793-7

How to access this item